(4-[1,2,4]Triazol-1-yl-phenyl)-acetic acid | 143426-64-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (4-[1,2,4]Triazol-1-yl-phenyl)-acetic acid
• 英文别名: 2-[4-(1,2,4-Triazol-1-yl)phenyl]acetic acid
• CAS: 143426-64-6
• 化学式: C₁₀H₉N₃O₂
• 分子量: 203.2
• InChiKey: SNZSNVCNDMDJOH-UHFFFAOYSA-N

物化性质

• 沸点：
  434.7±47.0 °C(Predicted)
• 密度：
  1.34±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  68
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (4-[1,2,4]Triazol-1-yl-phenyl)-acetic acid 在 草酰氯 、 氨 、 N,N-二甲基甲酰胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 14.0h， 生成
  参考文献：
  名称：

  Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor

  摘要：

  DOI：

  10.1016/j.bmcl.2021.127846
• 作为产物：
  描述：

  4-(1,2,4-三唑-1-基)苯甲醇 在 盐酸 、 氯化亚砜 作用下， 以 乙腈 为溶剂， 反应 75.5h， 生成 (4-[1,2,4]Triazol-1-yl-phenyl)-acetic acid
  参考文献：
  名称：

  Aromatic hydrazides as specific inhibitors of bovine serum amine oxidase

  摘要：

  New hydrazides were synthesized in search for specific inhibitors of bovine serum amine oxidase: a series of benzoic and phenylacetic acid hydrazides containing the 1H-imidazol-1-yl or the 1H-imidazol-1-ylmethyl group as (o, m, p)-substituent in the phenyl ring; an analogous series of p-substituted phenylhydrazides with 5 or 6-membered heterocyclic ring as substituent, and a series of similar phenylpropionic hydrazides. The longer and more flexible phenylacetic hydrazides, and to a somewhat lesser extent the phenylpropionic ones, were better specific inhibitors of bovine serum amine oxidase than the benzoic hydrazides, which were also bound by the enzyme with high affinity, but at a slow rate. Derivatives with p- and m -substituents were more reactive than the o-substituted ones. The chemical nature of the substituent was less important than its position in the phenyl ring and the presence of methylene spacers. These data point to the presence of a hydrophobic site at short distance from the protein carbonyl cofactor, so that simultaneous interaction of the 2 ends of the inhibitor molecule can occur at the 2 sites. The presence of the hydrophobic site was confirmed by the capability of some molecule deprived of the hydrazidic group to act as mild inhibitors. All hydrazides were less reactive by 2-3 orders of magnitude towards pig kidney diamine oxidase and FAD-dependent monoamine oxidase from rat brain mitochondria, while the other compounds showed similar inhibition power against all proteins. The specificity for the bovine enzyme seems therefore to be related to the concerted action of the 2 moieties of the inhibitor molecule.

  DOI：

  10.1016/0223-5234(92)90005-l

文献信息

• Tri(cyclo) substituted amide compounds
  申请人：——

  公开号：US20040181067A1

  公开（公告）日：2004-09-16

  Compounds of Formula (I): 1 or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

  公式（I）化合物或其药学上可接受的盐，可用于预防和治疗高血糖和糖尿病。
• Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10
  作者：Risto O. Juvonen、Sanna Rauhamäki、Sami Kortet、Sanna Niinivehmas、Johanna Troberg、Aleksanteri Petsalo、Juhani Huuskonen、Hannu Raunio、Moshe Finel、Olli T. Pentikäinen

  DOI：10.1021/acs.molpharmaceut.7b00871

  日期：2018.3.5

  Intestinal and hepatic glucuronidation by the UDP-glucuronosyltransferases (UGTs) greatly affect the bioavailability of phenolic compounds. UGT1A10 catalyzes glucuronidation reactions in the intestine, but not in the liver. Here, our aim was to develop selective, fluorescent substrates to easily elucidate UGT1A10 function. To this end, homology models were constructed and used to design new substrates, and subsequently, six novel C3-substituted (4-fluorophenyl, 4-hydroxyphenyl, 4-methoxyphenyl, 4-(dimethylamino)phenyl, 4-methylphenyl, or triazole) 7-hydroxycoumarin derivatives were synthesized from inexpensive starting materials. All tested compounds could be glucuronidated to nonfluorescent glucuronides by UGT1A10, four of them highly selectively by this enzyme. A new UGT1A10 mutant, 1A10-H210M, was prepared on the basis of the newly constructed model. Glucuronidation kinetics of the new compounds, in both wild-type and mutant UGT1A10 enzymes, revealed variable effects of the mutation. All six new C3-substituted 7-hydroxycoumarins were glucuronidated faster by human intestine than by liver microsomes, supporting the results obtained with recombinant UGTs. The most selective 4(dimethylamino)phenyl and triazole C3-substituted 7-hydroxycoumarins could be very useful substrates in studying the function and expression of the human UGT1A10.
• PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE MODULATORS
  申请人：Prosidion Limited

  公开号：EP1594867A2

  公开（公告）日：2005-11-16
• US7214681B2
  申请人：——

  公开号：US7214681B2

  公开（公告）日：2007-05-08
• [EN] TRI(CYCLO) SUBSTITUTED AMIDE COMPOUNDS<br/>[FR] COMPOSES D'AMIDES SUBSTITUES TRI(CYCLO)
  申请人：OSI PHARM INC

  公开号：WO2004072031A2

  公开（公告）日：2004-08-26

  Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.